Understanding Radiology in HPP: Why Bone Density Scans Can Be Misleading

Hypophosphatasia (HPP) is a rare metabolic bone disease caused by low activity of the enzyme alkaline phosphatase. This deficiency impairs mineralization of bone and teeth, leading to a spectrum of skeletal problems—from mild stress fractures in adults to life-threatening complications in infants. Clinicians often rely on imaging to assess bone health, but standard tools may not tell the full story in HPP. In particular, “bone density scans” such as DEXA can be misleading. This guide explains why, compares DEXA to radionuclide bone scans, and offers practical advice for patients and healthcare providers.

---

1. What Each Scan Measures

DEXA Scan (Dual-Energy X-ray Absorptiometry)

• Uses two X-ray beams at different energies to estimate areal bone mineral density (BMD) in g/cm².
• Commonly applied to lumbar spine, hip, and sometimes forearm.
• Provides T-scores and Z-scores to categorize osteoporosis or low bone mass.

Radionuclide Bone Scan (Bone Scintigraphy)

• Involves injection of a small amount of radioactive tracer (technetium-99m-labeled diphosphonates).
• Detects regions of increased bone turnover (“hot spots”) and low activity (“cold spots”).
• Highlights areas of stress reaction, healing fractures, infection, or tumor.

---

2. Why DEXA Results May Be Misleading in HPP

1. Two-Dimensional Data
   DEXA reports areal BMD (g/cm²), which does not account for bone depth or geometry. In HPP, changes in bone thickness, shape, and mineralization patterns can skew results.

2. Bone Quality vs. Quantity
   HPP affects how bone is mineralized, not just how much mineral is present. DEXA cannot assess microarchitecture, collagen integrity, or crystal size.

3. Pseudofractures and Sclerosis
   Radiographically, HPP can show zones of cortical thickening or “sclerotic bands” around pseudofractures. These high-density regions may artificially elevate DEXA scores, suggesting normal or even high BMD despite poor bone strength.

4. Site-Specific Variability
   The pelvis and spine may appear denser, while weight-bearing long bones remain weak. A standard DEXA of the hip and spine won’t capture problems in the forearm or tibia where stress fractures often occur in adult HPP.

5. T-Score/Z-Score Misclassification
   Standard reference data are derived from healthy populations. In HPP, comparing to these norms can misclassify severity, delaying diagnosis or appropriate treatment.

---

3. How Bone Scans Can Add Clarity

Radionuclide bone scans don’t measure density—they show bone metabolic activity. In HPP, you might see:

• Hot Spots at sites of stress reaction or pseudofracture.
• Increased Uptake where microdamage is being remodeled.
• Cold Areas in regions of poor blood supply or impaired turnover.

These patterns help distinguish true fractures from healed or inactive lesions. A bone scan is particularly useful when:

• DEXA is unexpectedly normal or elevated despite symptoms.
• You suspect multiple stress fractures that X-rays fail to reveal.
• You need a full-body overview to localize active disease sites.

---

4. Advanced Imaging Options

When standard scans don’t align with clinical findings, consider:

• Quantitative Computed Tomography (QCT)
  Measures volumetric BMD (mg/cm³) and can differentiate cortical vs. trabecular bone. Better for small bones and assessing geometry.

• High-Resolution Peripheral QCT (HR-pQCT)
  Provides 3D images of bone microarchitecture in the wrist and ankle.

• MRI
  Detects bone marrow changes, edema, and soft-tissue involvement around stress injuries.

These tools offer deeper insight into bone strength, structure, and the healing process.

---

5. Putting It All Together: A Multimodal Approach

In HPP, no single test gives a complete picture. Optimal assessment combines:

1. Clinical Evaluation
   History of fractures, dental issues (early tooth loss), muscle pain, and family history.

2. Laboratory Studies

   • Serum alkaline phosphatase (ALP) levels—typically low in HPP.
   • Substrates such as plasma pyridoxal-5′-phosphate (PLP) and urine phosphoethanolamine (PEA).

3. Genetic Testing
   Mutations in the ALPL gene confirm the diagnosis and help clarify prognosis.

4. Imaging

   • DEXA for a baseline areal BMD.
   • Bone scan to detect active lesions.
   • Advanced modalities (QCT, HR-pQCT, MRI) as needed.

5. Functional Assessment
   Gait analysis, muscle strength testing, and evaluation of daily living activities.

---

6. Key Differences: Hypophosphatasia Bone Scan vs. DEXA Scan

Feature	DEXA Scan	Bone Scan (Scintigraphy)
Primary Measure	Areal BMD (g/cm²)	Bone turnover / metabolic activity
Dimensionality	2D	Whole-body 3D activity map
Sensitivity in HPP	Low (may overestimate density)	High (detects active lesions)
Microarchitecture Detail	None	None (but highlights remodeling sites)
Typical Use	Osteoporosis screening	Fracture localization, tumor/infection
Radiation Dose	Low	Low-moderate

---

7. Practical Tips for Patients and Providers

• Don’t Rely on DEXA Alone
  If you have HPP symptoms—bone pain, recurrent fractures, dental problems—ask for a bone scan or advanced imaging.

• Interpret Scores in Context
  A “normal” DEXA doesn’t rule out HPP. Look at clinical signs, lab values, and genetic data.

• Monitor Over Time
  Repeat imaging may be needed to track pseudofracture healing or disease progression.

• Share Full History
  Always tell your radiologist and endocrinologist about any HPP diagnosis, family history, or childhood fractures.

• Explore a Free Symptom Check
  Before your appointment, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help organize your concerns and prepare questions.

---

8. When to Speak to a Doctor

If you experience any of the following, seek medical advice promptly:

• Sudden or severe bone pain, especially after minimal trauma.
• Swelling or bruising over a bone without a clear injury.
• Tooth loss in adults without gum disease.
• Muscle weakness or difficulty walking.

Always discuss imaging results and next steps with a healthcare professional. Imaging findings can be complex and need expert interpretation within the context of your overall health.

---

9. Conclusion

Radiology in hypophosphatasia requires a tailored approach. While DEXA scans are invaluable in osteoporosis, they can miss or misinterpret critical aspects of HPP. Radionuclide bone scans, combined with advanced imaging, lab studies, and genetic testing, offer a clearer view of bone health. By understanding the strengths and limits of each modality, you and your care team can make informed decisions, reduce misdiagnosis, and improve long-term outcomes.

If you suspect HPP or have unexplained bone symptoms, prioritize a comprehensive evaluation. And remember, imaging is just one piece of the puzzle—always speak to a doctor for any serious or life-threatening concerns.